T cells targeting multiple tumor-associated antigens as a postremission treatment to prevent or delay relapse in acute myeloid leukemia

BACKGROUND: Relapse is a major problem in acute myeloid leukemia (AML) and adversely affects survival. Tumor-associated antigen-specific cytotoxic T lymphocyte (TAA-CTLs)-based therapy was introduced and increasingly used clinically to kill tumor cells via tumor antigen activation. METHOD: In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Lei, Hu, Yan, Wang, Jian, Liu, Xin, Wang, Xingbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642655/
https://www.ncbi.nlm.nih.gov/pubmed/31406473
http://dx.doi.org/10.2147/CMAR.S205296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642655/
https://www.ncbi.nlm.nih.gov/pubmed/31406473
http://dx.doi.org/10.2147/CMAR.S205296

Ejemplares similares